Answers are grounded in this paper and cite their sources.
A nanoparticle Epstein-Barr virus glycoprotein gH/gL vaccine elicits antibodies that mediate cell type–independent protection from infection.
No takes yet. Share an insight, caveat, or question.
Michelle J. Boyle (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: